Product Images Chlorpromazine Hci

This is a drug label for Chlorpromazine HCI Injection, USP with NDC identifier 0641-1356-31. It contains 25 mg/mL and is meant for deep intramuscular use only. The drug is packaged in a 2 mL ampule. The label also includes storage instructions to protect the drug from light. However, no information is available regarding the manufacturer or the expiration date.*

This text is a warning about the increased risk of death in elderly patients with dementia-related psychosis who are treated with antipsychotic drugs. According to the findings of several placebo-controlled trials, the use of antipsychotic drugs increases the risk of death by 1.6 to 1.7 times compared to patients who did not receive the medication. The causes of death were mostly found to be cardiovascular or infectious in nature. Though conventional antipsychotic drugs also increase mortality, their contribution to the risk of death is not very clear. It is of note that Chlorpromazine Hydrochloride Injection, USP is not approved for use in treating dementia-related psychosis.*

This text appears to be information related to a medication. The medication is Chlorpromazine HCI Injection, USP and it has a product code of NOG G541-1396-31. The text also includes a manufacturer's package number and a distributor of the medication. The string "00351662140611" does not appear to be related to medication information and the rest of the characters are possibly part of a packaging or labeling system.*